Amondarain M y cols. Trasplante hepáꢀco en colangiocarcinoma perihiliar irresecable. Rev Argent Cir. 2026;118(2):e-1935
3
espera, principalmente colangiꢀs asociada a drenajes años superiores al 60% en pacientes trasplantados bajo
biliares, el control tumoral se mantuvo, situación tam- protocolo, posicionando al trasplante hepáꢀco como la
bién descripta en hasta el 40% de los pacientes inclui- mejor alternaꢀva curaꢀva disponible para CCpH irre-
5
dos en protocolos de trasplante para CCpH, sin impacto secable en centros especializados . En línea con estos
negaꢀvo en la supervivencia cuando el protocolo se resultados, el paciente permanece libre de enfermedad
completa adecuadamente. La laparoscopia de esta- al año del trasplante, con seguimiento trimestral me-
dificación desempeñó un papel central, permiꢀendo diante marcadores tumorales, resonancia magnéꢀca
descartar diseminación peritoneal oculta, hallazgo in- abdominal y tomograꢁa computarizada de tórax, sin
formado en hasta el 20% de los pacientes evaluados ini- evidencia de recurrencia, y sin tratamiento adyuvante.
cialmente como candidatos a trasplante en series con-
En conclusión, el trasplante hepáꢀco bajo pro-
4
temporáneas . Asimismo, la ausencia de compromiso tocolo representa una opción curaꢀva real para pa-
distal de la vía biliar permiꢀó evitar una duodenopan- cientes seleccionados con CCpH irresecable. Este caso
createctomía cefálica asociada, reduciendo la morbili- ejemplifica su éxito cuando se aplica conforme a la
dad operatoria sin comprometer el control oncológico.
evidencia vigente y destaca la importancia de centros
Algunos metanálisis recientes confirman la so- especializados, selección rigurosa y abordaje mulꢀdis-
6
lidez de esta estrategia, con supervivencias globales a 5 ciplinario .
■
ENGLISH VERSION
Perihilar cholangiocarcinoma (pCCA) is the and histological analysis showed findings consistent
most common type of extrahepaꢀc bile duct cancer. with reacꢀve inflammaꢀon, with no evidence of
The locaꢀon of the tumor at the confluence of the malignancy.
hepaꢀc ducts complicates early diagnosis and, in
During follow-up, the paꢀent developed
most cases, precludes the possibility of surgical four episodes of cholangiꢀs which were treated
resecꢀon with negaꢀve margins. Curaꢀve resecꢀon with intravenous anꢀbioꢀcs and replacement of
remains the standard of care when feasible, but in percutaneous drains. The tumor markers (CEA, CA
paꢀents with locally advanced disease and absence of 19-9) were within normal ranges. Positron emission
distant metastasis, the prognosis remains poor with tomography/computed tomography (PET/CT) scan
1
convenꢀonal therapies .
demonstrated nonspecific uptake at the biliary
In recent decades, liver transplantaꢀon has confluence suggesꢀve of inflammaꢀon, with no
emerged as a therapeuꢀc opꢀon for paꢀents with evidence of metastaꢀc disease.
unresectable pCCA, parꢀcularly within the context
The case was evaluated in a mulꢀdisciplinary
of protocols that combine neoadjuvant therapy and case conference. The paꢀent was proposed for
strict selecꢀon criteria, such as the one developed inclusion in the insꢀtuꢀonal liver transplantaꢀon
by the Mayo Clinic. This approach has demonstrated protocol for unresectable pCCA. The protocol consists
long-term survival rates that are significantly higher of neoadjuvant chemoradiotherapy followed by
than those achieved with resecꢀon in selected cases. liver transplantaꢀon, with concomitant cephalic
Five-year survival rates range from 65% to 75%. These pancreaꢀcoduodenectomy (CPD) if staging laparoscopy
results far exceed those obtained with resecꢀon confirms tumor involvement of the distal bile duct or
in advanced cases, especially when achieving clear pancreatoduodenal structures.
2
margins is difficult, and the disease is locally advanced .
He received external radiaꢀon therapy (50 Gy)
We report the case of a 52-year-old otherwise (Figs. 1 and 2), concurrent with 5-FU chemotherapy
healthy male paꢀent who presented with obstrucꢀve according to protocol.
jaundice lasꢀng 48 hours in July 2023. On magneꢀc
An exploratory laparoscopy, peritoneal biopsy,
resonance imaging, the intrahepaꢀc bile ducts were and hepaꢀc lymphadenectomy were performed in
dilated and presented a stricture at the confluence. March 2024. There was no evidence of metastasis.
Percutaneous biliary drains and metallic stents were
In December 2024, the paꢀent underwent
inserted using transhepaꢀc cholangiography. The orthotopic cadaveric liver transplantaꢀon without
diagnosis was unresectable pCCA due to bilateral significant intraoperaꢀve complicaꢀons. The biliary tract
involvement of hepaꢀc vascular structures.
was secꢀoned and submiꢂed for frozen secꢀon. Since
Linear endoscopic ultrasound idenꢀfied three the margins were clear, CPD was not necessary, and the
peripancreaꢀc lymph nodes (12–17 mm) and two hilar decision was made to proceed with the liver transplant.
lymph nodes (12–14 mm). No secondary pancreaꢀc
An end-to-side Roux-en-Y biliary anastomosis
or vascular involvement was observed. Samples were was performed. The paꢀent evolved with favorable
obtained with a 25G ProCore needle. The cytological outcome. The pathological examinaꢀon revealed